Patent ID: 6191162
Filing Date: 2001-02-20
Classification: A61K,Y10S

Abstract:
A method of reducing a patient's serum glucose level, comprising:administering to the patient a therapeutically effective amount of controlled release lipoic acid,wherein the lipoic acid is delivered to the patient's circulatory system at a continual rate over a period of four hours or more;wherein the lipoic acid is administered orally;wherein the lipoic acid is a racemic mixture administered in an amount in a range of from about 100 mg to about 1,000 mg; andwherein the lipoic acid composes a mixture of R-(+)-.alpha.-lipoic acid and S-(-)-.alpha.-lipoic acid, and ratio of R-(+)-.alpha.-lipoic acid to S-(-)-.alpha.-lipoic acid ranges from about 90:10 to about 10:90, respectively based on weight.